What is it about?
Amenorrheic women (median age 28) with central (hypogonadotropic, secondary) hypogonadism had higher cholesterol and triglyceride levels compaired to healthy women of similar age. Treatment with estradiol 2 mg and dydrogesterone 10 mg leaded to significant decrease of cholesterol and triglyceride levels
Featured Image
Why is it important?
Central hypogonadism in young women is usually considered as reproductive disorder. However, we found metabolic consequences of hypoestrogenemia, and showed it's regress on hormonal treatment
Read the Original
This page is a summary of: Narusheniya lipidnogo spektra i ikh korrektsiya u patsientok s gipogonadotropnym gipogonadizmom, Obesity and metabolism, September 2006, Endocrinology Research Centre,
DOI: 10.14341/2071-8713-5260.
You can read the full text:
Contributors
The following have contributed to this page
